2m 2m 2m 2m 2m 2m 2m
Stem Holdings (STMH)
OTC
$0.000001$0.00 (0.00%)
Price as of May 18, 2026- $6.00Market Cap
- 0.00%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Stem Holdings (STMH)
$0.000001$0.00 (0.00%)
Annual
Quarterly
09/30/2023 | 09/30/2022 | 09/30/2021 | 09/30/2020 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | 16.6M -53.69% | 35.8M +155.97% | 14.0M N/A | |
Cost of Revenue | N/A N/A | 14.4M -48.76% | 28.2M +173.46% | 10.3M N/A | |
Gross Profit | 0 -100.00% | 2.1M -72.01% | 7.6M +106.82% | 3.7M N/A | |
Sales and Marketing Expense | 103,000 -61.28% | 266,000 +26,500.00% | 1,000 -100.00% | 66.5M N/A | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | N/A N/A | 1.6M -16.48% | 1.9M -18.43% | 2.4M N/A | |
Total Operating Expenses | 3.7M -83.81% | 23.2M -69.32% | 75.5M +465.85% | 13.3M N/A | |
Operating Profit | -3.7M -82.18% | -21.0M -69.01% | -67.9M +602.09% | -9.7M N/A | |
Interest Income | N/A N/A | 2.0M -13.32% | 2.3M +16,357.14% | 14,000 N/A | |
Interest Expense | -1.2M +90.46% | -650,000 N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | -1.2M -191.91% | 1.3M -41.54% | 2.3M +16,357.14% | 14,000 N/A | |
Total Nonoperating Income and Expense | -1.4M -132.25% | 4.4M +26.35% | 3.5M +321.86% | -1.6M N/A | |
Income before Taxes | -5.2M -68.89% | -16.6M -75.52% | -67.9M +602.09% | -9.7M N/A | |
Income Taxes | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Extraordinary Items | 1.5M -74.61% | 5.9M +168.50% | 2.2M +214.29% | 700,000 N/A | |
Net Income | -19.0M +9.50% | -17.4M -73.02% | -64.4M +485.02% | -11.0M N/A | |
Net Income from Continuing Operations Applicable to Common | -5.2M -68.89% | -16.6M -74.18% | -64.4M +485.02% | -11.0M N/A | |
Basic EPS and Net Income | -7.67 +9,487.50% | -0.08 -80.00% | -0.40 +122.22% | -0.18 N/A | |
Diluted EPS and Net Income | -7.67 +9,487.50% | -0.08 -80.00% | -0.40 +122.22% | -0.18 N/A | |
Basic Weighted Average Shares | 2.5M -98.88% | 226.2M +41.97% | 159.3M +164.88% | 60.1M N/A | |
Diluted Weighted Average Shares | 2.5M -98.88% | 226.2M +41.97% | 159.3M +164.88% | 60.1M N/A | |
Balance Sheet | |||||
Cash and Cash Equivalents | 961,000 -36.94% | 1.5M -72.64% | 5.6M +161.63% | 2.1M N/A | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 961,000 -36.94% | 1.5M -72.64% | 5.6M +161.63% | 2.1M N/A | |
Total Current Assets | 13.3M +144.79% | 5.4M -57.63% | 12.8M +143.93% | 5.3M N/A | |
Accumulated Depreciation | N/A N/A | 5.8M +2.56% | 5.7M +36.40% | 4.2M N/A | |
Property and Plant and Equipment and Net | N/A N/A | 9.1M -27.92% | 12.6M -22.89% | 16.4M N/A | |
Total Long-Term Assets | N/A N/A | 9.1M -27.92% | 12.6M -22.89% | 16.4M N/A | |
Total Assets | 13.3M -56.92% | 31.0M -45.83% | 57.2M +27.04% | 45.0M N/A | |
Income Taxes Payable | N/A N/A | 120,000 N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 2.3M -20.08% | 2.9M -23.35% | 3.8M -57.23% | 8.9M N/A | |
Total Current Liabilities | 14.0M +123.90% | 6.2M -60.48% | 15.8M +8.95% | 14.5M N/A | |
Total Long-Term Debt | 1.2M -49.22% | 2.4M +16.29% | 2.1M -43.01% | 3.7M N/A | |
Total Long-Term Liabilities | 134,000 -97.95% | 6.5M -21.69% | 8.3M +111.57% | 3.9M N/A | |
Total Liabilities | 14.0M +0.24% | 13.9M -39.25% | 23.0M +26.22% | 18.2M N/A | |
Retained Earnings | -152.1M +14.29% | -133.1M +15.00% | -115.8M +125.26% | -51.4M N/A | |
Total Stockholders Equity | -1.7M -111.04% | 15.6M -52.26% | 32.6M +30.42% | 25.0M N/A | |
Total Shares Outstanding | 2.8M -98.76% | 227.0M -1.61% | 230.7M +238.04% | 68.3M N/A | |
Cash Flow | |||||
Cash from Operating Activities | -1.2M -80.90% | -6.5M -29.51% | -9.2M +82.44% | -5.0M N/A | |
Capital Expenditures | N/A N/A | 215,000 -62.74% | 577,000 +22.51% | 471,000 N/A | |
Cash from Investing Activities | N/A N/A | 3.2M +1,509.09% | 198,000 +137.01% | -535,000 N/A | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 1.2M +284.39% | -660,000 -105.32% | 12.4M +185.23% | 4.4M N/A | |
Financials Ratio | |||||
Gross Margin | N/A N/A | 12.82% -39.56% | 21.21% -19.20% | 26.25% N/A | |
Operating Margin | N/A N/A | -126.96% -33.08% | -189.73% +174.29% | -69.17% N/A | |
Return on Assets | -85.81% +117.80% | -39.40% -68.72% | -125.95% +335.68% | -28.91% N/A | |
Return on Equity | -274.81% +280.95% | -72.14% -67.73% | -223.54% +365.92% | -47.98% N/A | |
Revenue Growth | N/A N/A | -53.69% -134.43% | 155.97% -66.82% | 470.13% N/A | |
Current Ratio | 0.95 +9.34% | 0.87 +7.20% | 0.81 +123.91% | 0.36 N/A | |
Cash Ratio | 0.07 -71.81% | 0.24 -30.77% | 0.35 +140.19% | 0.15 N/A | |
Debt-to-Equity Ratio | -2.08 -703.85% | 0.35 +90.03% | 0.18 -64.03% | 0.50 N/A | |
Debt-to-Assets Ratio | 0.27 +54.76% | 0.17 +67.44% | 0.10 -63.06% | 0.28 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow